Ghulam Md Ashraf Selected Research

Raloxifene Hydrochloride (Evista)

4/2020	Raloxifene potentiates the effect of fluoxetine against maximal electroshock induced seizures in mice.
2/2019	The Synergistic Effect of Raloxifene, Fluoxetine, and Bromocriptine Protects Against Pilocarpine-Induced Status Epilepticus and Temporal Lobe Epilepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ghulam Md Ashraf Research Topics

Disease

58	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2013
41	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2024 - 01/2018
36	Neoplasms (Cancer) 09/2023 - 08/2007
16	Inflammation (Inflammations) 12/2023 - 01/2017
13	Parkinson Disease (Parkinson's Disease) 04/2024 - 01/2015
12	Nervous System Diseases (Neurological Disorders) 01/2023 - 01/2015
12	Dementia (Dementias) 11/2022 - 01/2013
11	Neuroinflammatory Diseases 10/2023 - 04/2019
9	Cognitive Dysfunction 04/2024 - 01/2019
8	Infections 08/2023 - 01/2016
7	Amyloid Plaque 05/2024 - 01/2019
7	Obesity 10/2022 - 01/2017
7	Insulin Resistance 05/2022 - 03/2014
6	Huntington Disease (Huntington's Disease) 12/2023 - 01/2020
6	Body Weight (Weight, Body) 01/2023 - 05/2016
5	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 01/2017
5	COVID-19 09/2023 - 03/2022
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 01/2015
5	Stroke (Strokes) 10/2022 - 01/2020
5	Type 2 Diabetes Mellitus (MODY) 05/2022 - 03/2014
4	Proteostasis Deficiencies 01/2024 - 01/2018
4	Carcinogenesis 01/2024 - 11/2015
4	Glioma (Gliomas) 11/2022 - 01/2017
4	Atherosclerosis 10/2022 - 01/2015
4	Disease Progression 09/2022 - 01/2020
4	Pain (Aches) 04/2022 - 01/2019
4	Multiple Sclerosis 03/2022 - 01/2017
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2022 - 01/2020
3	Hyperglycemia 05/2022 - 01/2015
3	Breast Neoplasms (Breast Cancer) 01/2019 - 01/2015
2	Psychotic Disorders (Schizoaffective Disorder) 04/2024 - 01/2021
2	Hypertension (High Blood Pressure) 10/2023 - 01/2022
2	Neuralgia (Stump Neuralgia) 09/2023 - 01/2020
2	Edema (Dropsy) 01/2023 - 09/2022
2	Brain Neoplasms (Brain Tumor) 11/2022 - 07/2022
2	Myocardial Infarction 10/2022 - 12/2016
2	Arthritis (Polyarthritis) 10/2022 - 01/2019
2	Brain Diseases (Brain Disorder) 07/2022 - 02/2022
2	Wounds and Injuries (Trauma) 07/2022 - 06/2018
2	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2015
13	AntioxidantsIBA 01/2024 - 05/2016
13	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2017
12	Amyloid (Amyloid Fibrils)IBA 05/2024 - 01/2015
11	CytokinesIBA 12/2023 - 01/2017
10	Amyloid beta-PeptidesIBA 01/2023 - 01/2019
9	Peptides (Polypeptides)IBA 12/2021 - 01/2015
8	PhytochemicalsIBA 01/2023 - 07/2020
8	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 01/2015
7	Neuroprotective AgentsIBA 05/2024 - 01/2017
7	MicroRNAs (MicroRNA)IBA 10/2023 - 01/2017
7	Insulin (Novolin)FDA Link 05/2022 - 03/2014
7	diazonaphthalenedisulfonic acid (NDS)IBA 02/2022 - 08/2019
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2017
6	EnzymesIBA 05/2024 - 01/2013
6	tau Proteins (tau Protein)IBA 09/2022 - 01/2015
6	FlavonoidsIBA 01/2022 - 01/2020
5	PolyphenolsIBA 01/2023 - 01/2013
5	Galectins (Galectin)IBA 09/2022 - 08/2007
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2014
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2015
4	SynucleinsIBA 01/2024 - 01/2018
4	Estrogens (Estrogen)FDA Link 01/2023 - 01/2019
4	LipidsIBA 01/2023 - 01/2019
4	VaccinesIBA 07/2022 - 01/2018
4	Therapeutic UsesIBA 06/2022 - 01/2021
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 01/2017
3	Antipsychotic Agents (Antipsychotics)IBA 04/2024 - 01/2021
3	CurcuminIBA 01/2024 - 11/2020
3	Phosphotransferases (Kinase)IBA 10/2023 - 08/2020
3	Peptide Hydrolases (Proteases)FDA Link 09/2023 - 01/2019
3	CarbohydratesIBA 05/2022 - 01/2015
3	MetalsIBA 01/2022 - 01/2018
3	GoldIBA 01/2021 - 01/2015
3	LigandsIBA 01/2019 - 01/2015
3	LectinsIBA 01/2015 - 08/2007
2	EndocannabinoidsIBA 05/2024 - 01/2020
2	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 01/2019
2	Galectin 3 (LGALS3)IBA 08/2023 - 01/2022
2	IronIBA 07/2023 - 01/2023
2	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 04/2023 - 08/2020
2	Amino Acids FDA Link 04/2023 - 08/2020
2	QuercetinIBA 01/2023 - 11/2020
2	AntigensIBA 01/2023 - 01/2020
2	EpitopesIBA 01/2023 - 11/2017
2	AndrogensIBA 01/2023 - 01/2017
2	Free RadicalsIBA 01/2023 - 01/2019
2	SteroidsIBA 01/2023 - 01/2021
2	Small Interfering RNA (siRNA)IBA 11/2022 - 01/2021
2	ChemokinesIBA 11/2022 - 01/2019
2	C-Reactive ProteinIBA 09/2022 - 12/2016
2	Immunoglobulin G (IgG)IBA 09/2022 - 01/2020
2	Interleukin-10 (Interleukin 10)IBA 09/2022 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 08/2022 - 01/2022
2	ResveratrolIBA 07/2022 - 11/2020
2	Antiviral Agents (Antivirals)IBA 07/2022 - 01/2018
2	CaspasesIBA 06/2022 - 04/2022

Therapy/Procedure

48	Therapeutics 01/2024 - 08/2007
7	Drug Therapy (Chemotherapy) 04/2022 - 01/2012
3	Immunotherapy 01/2020 - 01/2015